Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
British Journal of Clinical Pharmacology|August 12, 2015
Antisense-mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first-in-human randomized, placebo-controlled trialEveline P van Poelgeest, Michael R Hodges, Matthijs Moerland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2025
Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS)Michael R Hodges, Margaret Tawadrous, Oliver A Cornely, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2018
Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1Joshua F Apgar, Jian-Ping Tang, Pratap Singh, et al.
The Journal of Antimicrobial Chemotherapy|August 19, 2023
Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trialPeter G Pappas, Jose A Vazquez, Ilana Oren, et al.
The New England Journal of Medicine|March 29, 2013
Treatment of HCV infection by targeting microRNAHarry L A Janssen, Hendrik W Reesink, Eric J Lawitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2022
Consensus Definitions of BK Polyomavirus Nephropathy in Renal Transplant Recipients for Clinical TrialsHannah Imlay, Paul Baum, Daniel C Brennan, et al.
Antiviral Research|September 15, 2014
Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patientsMeike H van der Ree, Adriaan J van der Meer, Joep de Bruijne, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 12, 2024
Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1Johanna R Abend, Atul Sathe, Matthias B Wrobel, et al.
The New England Journal of Medicine|August 9, 2002
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosisRaoul Herbrecht, David W Denning, Thomas F Patterson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2023
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical NeedYuliya Yasinskaya, Shukal Bala, Ursula Waack, et al.
Pageof 2